Press Releases Latest Sep 26, 2023 Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates Press Releases Year None20232022202120202019201820172016201520142013 Sep 26, 2023 Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates Sep 25, 2023 Theratechnologies Announces Agreement in Principle with Marathon to Amend Some of the Terms and Conditions of its Loan Facility Sep 25, 2023 Theratechnologies Submits Tesamorelin F8 Formulation sBLA for FDA Review Sep 20, 2023 Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023 Sep 18, 2023 Theratechnologies to Announce Third Quarter 2023 Financial Results and Provide Business Update Sep 07, 2023 Theratechnologies to Present at the H.C. Wainwright 25th Annual Global Investment Conference Sep 05, 2023 Theratechnologies Announces Certain Preliminary Q3 2023 Financial Highlights Aug 30, 2023 Theratechnologies Announces All U.S. Oncology Clinical Sites Now Enrolling for Phase 1 Trial of Sudocetaxel Zendusortide Jul 31, 2023 Theratechnologies Completes 1-for-4 Reverse Stock Split Jul 28, 2023 Theratechnologies Announces Amendments to its Term Loan Facility With Affiliates of Marathon Asset Management Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page › Last page » Displaying 1 - 10 of 328
Sep 26, 2023 Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
Sep 26, 2023 Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates
Sep 25, 2023 Theratechnologies Announces Agreement in Principle with Marathon to Amend Some of the Terms and Conditions of its Loan Facility
Sep 18, 2023 Theratechnologies to Announce Third Quarter 2023 Financial Results and Provide Business Update
Sep 07, 2023 Theratechnologies to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Aug 30, 2023 Theratechnologies Announces All U.S. Oncology Clinical Sites Now Enrolling for Phase 1 Trial of Sudocetaxel Zendusortide
Jul 28, 2023 Theratechnologies Announces Amendments to its Term Loan Facility With Affiliates of Marathon Asset Management
